AGIO vs. VEXMX

The year-to-date returns for both investments are quite close, with AGIO having a -3.10% return and VEXMX slightly higher at -3.00%. Over the past 10 years, AGIO has underperformed VEXMX with an annualized return of -12.59%, while VEXMX has yielded a comparatively higher 8.37% annualized return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Agios Pharmaceuticals, Inc. (AGIO) and Vanguard Extended Market Index Fund (VEXMX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current AGIO Sharpe Ratio is -0.29, which is lower than the VEXMX Sharpe Ratio of 0.42. The chart below compares the historical Sharpe Ratios of AGIO and VEXMX, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

AGIO has not paid dividends to shareholders, while VEXMX's dividend yield for the trailing twelve months is around 1.08%.

The maximum AGIO drawdown since its inception was -87.36%, which is greater than VEXMX's maximum drawdown of -58.17%. Use the drawdown chart below to compare losses from any high point for AGIO and VEXMX.

Agios Pharmaceuticals, Inc. (AGIO) has a higher volatility of 12.60% compared to Vanguard Extended Market Index Fund (VEXMX) at 6.21%. This indicates that AGIO's price experiences larger fluctuations and is considered to be riskier than VEXMX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.